Drug Type Gene editing |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Beijing Chigenovo Co., Ltd.Startup |
Active Organization Beijing Chigenovo Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Retinitis Pigmentosa | Preclinical | CN | Beijing Chigenovo Co., Ltd.Startup | 01 Aug 2023 |